has Server used IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2004-01-14 (15 years, 309 days) and hosted in Austin United States, server ping response time 129 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Kerberosproximalsolutions keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

Notice! No data available for this site.

Hosting Provider

Region: TX
City: Austin
Postal Code: 78744
Latitude: 30.176000595093
Longitude: -97.737297058105
Area Code: 512
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain

New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently (20 seconds ago) (0 seconds ago) (0 seconds ago) (0 seconds ago) (21 seconds ago) (1 seconds ago) (2 seconds ago) (13 seconds ago) (1 seconds ago) (14 seconds ago) (15 seconds ago) (15 seconds ago) (2 seconds ago) (0 seconds ago) (6 seconds ago) (33 seconds ago) (17 seconds ago) (0 seconds ago) (6 seconds ago) (29 seconds ago)

Results For Websites Listing

Found 41 Websites with content related to this domain, It is result after search with search engine

Kerberos Proximal Solutions Inc. | Research Corporation

Kerberos Proximal Solutions Inc., was founded to develop a proximal embolic-protection technology to recover debris dislodged during angioplasty and stent placement. Kerberos launched its lead product for coronary and peripheral use under the Rinspiration System™.

Kerberos Proximal Solutions, Acquired by FoxHollow

Kerberos Proximal Solutions was acquired by FoxHollow Technologies on August 28, 2006. Join Mergr to view this profile - and discover more medical products acquisitions of companies like Kerberos Proximal Solutions.

Kerberos Proximal Solutions | DAIC

Newsletters. Enter your email address and name below to subscribe to any of our free e-newsletters.

Kerberos Proximal Solutions | RadcliffeCardiology

RadcliffeCardiology devices & diagnostics Kerberos Proximal Solutions covering. Respected digital resource of independent, expert-led cardiovascular education through the provision of a personalised learning experience

Kerberos Proximal Solutions | Evaluate

The latest news, comment and analysis about Kerberos Proximal Solutions from the Vantage editorial team.

Kerberos Proximal Solutions Inc. :: Medtech Insight

Kerberos Proximal Solutions Inc. This article was originally published in Start Up. 01 Dec 2002; Executive Summary Kerberos' KEPTembolic protection catheter system uses an alternating rinsing and aspiration action -- "Rinspiration" -- to capture and retrieve more embolic mass, including small particles.

QT Vascular Directors, Arterial, Balloon Catheter | QTVascular

Board of Directors. Amir Belson, M.D. was the founder of Neoguide Systems, that was acquired by Intuitive Surgical in 2009, Vascular Pathways, a vascular intervention technology which was acquired by C R Bard, Zipline Medical, a wound closure technology company, Qool Therapeutics, a minimally invasive therapeutic hypothermia technology company

fred volinsky - CEO - Epiphany Biosciences | LinkedIn

View fred volinsky’s profile on LinkedIn, the world's largest professional community. fred has 2 jobs listed on their profile. See the complete profile on LinkedIn and discover fred’s

Kerberos to Sell FDA Cleared Rinspiration Technology

Kerberos Proximal Solutions was a privately-held medical device company based in Cupertino, Calif. Founded in 2001, Kerberos was dedicated to developing innovative solutions to treat vascular

Kerberos Proximal Solutions Announces 200th Rinspiration

Kerberos Proximal Solutions Inc. performed its 200th case of Rinspiration this week. Jeffrey Moses, M.D., performed the case at New York Presbyterian/Columbia University Medical Center (NYP/CUMC). Dr. Moses used the Rinspiration System™ in a challenging coronary intervention.

Recently Analyzed Sites